Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Xing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3356-9108; OpenAlex author ID A5004723028. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

  1. PARP9 drives the malignant progression of pancreatic cancer cells by regulating apoptosis, DNA damage, and multidrug efflux systems. Co-author DOI 10.3389/fcell.2025.1694345↗
  2. Crosstalk between metabolic remodeling and epigenetic reprogramming: A new perspective on pancreatic cancer. Co-author DOI 10.1016/j.canlet.2024.216649↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yulan Li · 1 shared paper, 2025 · strength 0.42
  2. Bo Ren · 1 shared paper, 2024 · strength 0.20
  3. Ming Cui · 1 shared paper, 2024 · strength 0.20
  4. Yuan Fang · 1 shared paper, 2024 · strength 0.20
  5. Jie Ren · 1 shared paper, 2024 · strength 0.20
  6. Yupei Zhao · 1 shared paper, 2024 · strength 0.20
  7. Lei You · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.